# GLP-1 Agonists

Type: Technology

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/glp-1-agonists
Canonical HTML page: https://gethealthbrief.com/entity/glp-1-agonists

## Timeline

- **2026-03-19**: Pitt Breakthrough — Researchers reveal a new approach to bypass leptin resistance at the molecular level.
- **2023**: GLP-1 Dominance — Drugs like Wegovy and Zepbound revolutionize the obesity market.
- **1995**: Clinical Failures — Early leptin trials fail due to the discovery of leptin resistance in obesity.
- **1994**: Discovery of Leptin — Jeffrey Friedman identifies the hormone as a key regulator of body weight.

## Recent coverage (1 stories)

### Pitt Researchers Unveil Novel Leptin-Based Obesity Treatment Strategy
2026-03-19 18:34:44 · Sentiment: Positive · Impact: 7/10 · Sources: 6

University of Pittsburgh researchers have identified a new mechanism to overcome leptin resistance, a major hurdle in obesity treatment. This approach aims to restore the brain's sensitivity to satiety signals, potentially offering a sustainable alternative to current GLP-1 therapies.
Full story: https://gethealthbrief.com/story/pitt-research-obesity-leptin-breakthrough

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.